相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Current status and future prospects of yellow fever vaccines
Andrew S. Beck et al.
EXPERT REVIEW OF VACCINES (2015)
Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans
Axel Ronald Schulz et al.
JOURNAL OF IMMUNOLOGY (2015)
A randomised double-blind clinical trial of two yellow fever vaccines prepared with substrains 17DD and 17D-213/77 in children nine-23 months old
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2015)
Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination
Rama S. Akondy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naive subjects
Sharon E. Frey et al.
VACCINE (2015)
Deaths following vaccination: What does the evidence show?
Elaine R. Miller et al.
VACCINE (2015)
Lessons learned from making and implementing vaccine recommendations in the US
L. Reed. Walton et al.
VACCINE (2015)
Risk groups for yellow fever vaccine-associated viscerotropic disease (YEL-AVD)
Stephen J. Seligman
VACCINE (2014)
Adverse events following yellow fever immunization: Report and analysis of 67 neurological cases in Brazil
Reinaldo de Menezes Martins et al.
VACCINE (2014)
Duration of post-vaccination immunity against yellow fever in adults
Iramaya Rodrigues Caldas et al.
VACCINE (2014)
Yellow fever vaccine-associated adverse events following extensive immunization in Argentina
Cristian Biscayart et al.
VACCINE (2014)
How advances in immunology provide insight into improving vaccine efficacy
Mark K. Slifka et al.
VACCINE (2014)
Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial
Mahboobeh Safaeian et al.
CANCER PREVENTION RESEARCH (2013)
Yellow fever revaccination guidelines change - a decision too feverish?
M. P. Grobusch et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Safety profile of the yellow fever vaccine Stamaril®: a 17-year review
Pascale Cottin et al.
EXPERT REVIEW OF VACCINES (2013)
Temporal Dynamics of the Primary Human T Cell Response to Yellow Fever Virus 17D As It Matures from an Effector- to a Memory-Type Response
Kim Blom et al.
JOURNAL OF IMMUNOLOGY (2013)
Yellow Fever Vaccination Elicits Broad Functional CD4+ T Cell Responses That Recognize Structural and Nonstructural Proteins
Eddie A. James et al.
JOURNAL OF VIROLOGY (2013)
Serologic assessment of yellow fever immunity in the rural population of a yellow fever-endemic area in Central Brazil
Vanessa Wolff Machado et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2013)
Demographic profile of sylvatic yellow fever in Brazil from 1973 to 2008
Fernando Portela Camara et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2013)
Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: A systematic review
Ellen Rafferty et al.
VACCINE (2013)
The role of health economic analyses in vaccine decision making
Steven Black
VACCINE (2013)
Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010
J. G. Breugelmans et al.
VACCINE (2013)
Yellow fever vaccination: Is one dose always enough?
Dipti Patel et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2013)
A humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow fever infection in an AG129/17D-204 peripheral challenge mouse model
Brett A. Thibodeaux et al.
ANTIVIRAL RESEARCH (2012)
The early cellular signatures of protective immunity induced by live viral vaccination
Siegfried Kohler et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Review of the risks and benefits of yellow fever vaccination including some new analyses
Thomas P. Monath
EXPERT REVIEW OF VACCINES (2012)
Development of a new hydrogen peroxide-based vaccine platform
Ian J. Amanna et al.
NATURE MEDICINE (2012)
Description of a Prospective 17DD Yellow Fever Vaccine Cohort in Recife, Brazil
Andrea Barbosa de Melo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Detection of Yellow Fever 17D Genome in Urine
Cristina Domingo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
An Inactivated Cell-Culture Vaccine against Yellow Fever
Thomas P. Monath et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: Systematic review
Roger E. Thomas et al.
VACCINE (2011)
Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model
Justin G. Julander et al.
VACCINE (2011)
Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella
Juliana Romualdo Nascimento Silva et al.
VACCINE (2011)
Short Report: Suspected Yellow Fever Vaccine-Associated Viscerotropic Adverse Events (1973 and 1978), United States
Thomas P. Monath
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2010)
Predicted 30-Year Protection After Vaccination With an Aluminum-Free Virosomal Hepatitis A Vaccine
Patrick A. Bovier et al.
JOURNAL OF MEDICAL VIROLOGY (2010)
Surveillance for adverse events following immunization (AEFI) in Switzerland-1991-2001
Z. Schumacher et al.
VACCINE (2010)
Inactivated yellow fever 17D vaccine: Development and nonclinical safety, immunogenicity and protective activity
Thomas P. Monath et al.
VACCINE (2010)
A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE®
Alfred von Krempelhuber et al.
VACCINE (2010)
Short Report: Incidence of Yellow Fever Vaccine-Associated Neurotropic Disease
Thomas Guimard et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2009)
Wanted, dead or alive: New viral vaccines
Ian J. Amanna et al.
ANTIVIRAL RESEARCH (2009)
Immunogenicity and Safety of Yellow Fever Vaccination for 102 HIV-Infected Patients
Olivia Veit et al.
CLINICAL INFECTIOUS DISEASES (2009)
The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response
Rama S. Akondy et al.
JOURNAL OF IMMUNOLOGY (2009)
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
Troy D. Querec et al.
NATURE IMMUNOLOGY (2009)
Viscerotropic disease following yellow fever vaccination in Peru
Alvaro Whittembury et al.
VACCINE (2009)
Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines
Joseph D. Miller et al.
IMMUNITY (2008)
Pressure-inactivated yellow fever 17DD virus:: Implications for vaccine development
Luciane P. Gaspar et al.
JOURNAL OF VIROLOGICAL METHODS (2008)
Adverse event reports following yellow fever vaccination
Nicole P. Lindsey et al.
VACCINE (2008)
Traditional smallpox vaccination with reduced risk of inadvertent contact spread by administration of povidone iodine ointment
Erika Hammartund et al.
VACCINE (2008)
Duration of humoral immunity to common viral and vaccine antigens
Ian J. Amanna et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005
Guilherme Cortes Fernandes et al.
VACCINE (2007)
Retrospective cost-effectiveness analyses for polio vaccination in the United States
Kimberly M. Thompson et al.
RISK ANALYSIS (2006)
Yellow fever vaccine-associated viscerotropic disease and death in Spain
A. Doblas et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil
AR Engel et al.
VACCINE (2006)
Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine
MJ Hepburn et al.
VACCINE (2006)
Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax™-DEN2) vaccine:: Phase I clinical trial for safety and immunogenicity
Farshad Guirakhoo et al.
HUMAN VACCINES (2006)
Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity
T Querec et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
The US-certified yellow fever vaccination center registry: A tool for travelers, state health departments, and vaccine providers
MN Russell et al.
JOURNAL OF TRAVEL MEDICINE (2006)
Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus
Y Edghill-Smith et al.
NATURE MEDICINE (2005)
Yellow fever vaccine: An updated assessment of advanced age as a risk factor for serious adverse events
AY Khromava et al.
VACCINE (2005)
Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial
LAB Camacho et al.
REVISTA DE SAUDE PUBLICA (2004)
Safety of the yellow fever vaccine during the September 2001 mass vaccination campaign in Abidjan, Ivory Coast
J Fitzner et al.
VACCINE (2004)
Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX®
S Kitchener
VACCINE (2004)
Cutting edge: Long-term B cell memory in humans after smallpox vaccination
S Crotty et al.
JOURNAL OF IMMUNOLOGY (2003)
Risk of anaphylaxis after vaccination of children and adolescents
K Bohlke et al.
PEDIATRICS (2003)
Duration of antiviral immunity after smallpox vaccination
E Hammarlund et al.
NATURE MEDICINE (2003)
Prevention of yellow fever in persons traveling to the tropics
TP Monath et al.
CLINICAL INFECTIOUS DISEASES (2002)
Comparative safety and immunogenicity of two yellow fever 17D vaccines (Arilvax and YF-VAX) in a Phase III multicenter, double-blind clinical trial
TP Monath et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2002)
Clinical proof of principle for ChimeriVax™:: recombinant live, attenuated vaccines against flavivirus infections
TP Monath et al.
VACCINE (2002)
Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases
PFC Vasconcelos et al.
LANCET (2001)
Intussusception among recipients of rotavirus vaccine: Reports to the vaccine adverse event reporting system
LR Zanardi et al.
PEDIATRICS (2001)
Surveillance for poliovirus vaccine adverse events, 1991 to 1998: Impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine
WA Wattigney et al.
PEDIATRICS (2001)
Population-based study of rotavirus vaccination and intussusception
P Kramarz et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2001)
Intussusception among infants given an oral rotavirus vaccine.
TV Murphy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
